Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030

globenewswire.com
PFE Pfizer Inc. is mentioned as a major industry player in the paclitaxel injection market, which is experiencing significant growth. The article does not provide specific sentiment towards Pfizer's performance or products. BMY Bristol-Myers Squibb Company is listed as a key company in the paclitaxel injection market. The article highlights the overall market growth but offers no specific sentiment or performance details for Bristol-Myers Squibb. ABT Abbott Laboratories is identified as a major player in the growing paclitaxel injection market. The article focuses on market trends and does not provide specific sentiment or performance analysis for Abbott. VTRS Viatris Inc. is mentioned as one of the major industry players in the paclitaxel injection market. The article discusses the overall market expansion but does not offer specific sentiment towards Viatris.

Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030 Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The paclitaxel injection market is on an upward trajectory, with forecasts indicating a rise from $6.82 billion in 2025 to $12.72 billion by 2030, at a CAGR of 13.4%. This growth is driven by increasing global cancer prevalence, improved oncology infrastructure, and a shift towards generic and biosimilar paclitaxel injections. Expanding clinical trials, advancements in drug formulation, and novel delivery technologies further bolster market expansion.

The demand for paclitaxel injections is significantly influenced by the growing incidence of breast cancer. According to a 2023 report by the American Cancer Society, approximately 297,790 cases of invasive breast cancer were diagnosed in the US alone. Paclitaxel injections are crucial in breast cancer treatment, disrupting cancer cell growth and aiding in curbing cancer spread. The rising prevalence of other cancers, exacerbated by factors such as tobacco and alcohol consumption, also propels the market forward. The National Cancer Institute projects global cancer cases to reach 29.9 million annually by 2040.

Innovative developments from leading companies are pivotal in the market's evolution. Notably, American Regent, Inc. launched an albumin-bound formulation in 2023, which enhances drug delivery and reduces toxicity, providing potentially life-extending benefits for patients with specific cancers. Such innovations underscore the focus on expanding treatment options and strengthening domestic pharmaceutical production.

Major industry players include Pfizer Inc., Bristol-Myers Squibb Company, Fresenius Kabi Oncology Ltd., Abbott Laboratories, and Viatris Inc., among others. These companies are strategically leveraging research and development to introduce advanced paclitaxel formulations, targeting various oncology indications.

Regionally, North America leads the paclitaxel injection market as of 2025, with Asia-Pacific poised for rapid growth. This growth is attributed to increased chemotherapy access, particularly in emerging markets.

Reasons to Purchase:

Markets Covered:

Key Companies: Pfizer Inc., Bristol-Myers Squibb, Fresenius Kabi, Abbott Laboratories, among others.

Countries: Includes major economies like the USA, China, India, and several European nations.

Regions: Global coverage including Asia-Pacific, Europe, North America, among others.

Time Series provides five-year historical and ten-year forecast data.

Data covers market size ratios, growth comparisons, GDP proportions, and competitor dynamics.

Key Attributes

The companies featured in this Paclitaxel Injection market report include:

For more information about this report visit https://www.researchandmarkets.com/r/b0u8lh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment